Is anybody stunned that Walgreens is trying to promote itself – reportedly to non-public fairness agency Sycamore Companions?

Walgreens has misplaced loads of {dollars} currently: as a lot as $8.6 billion of them in fiscal yr 2024. Its foray into major care has been a problem and compelled the nation to shut a string of VillageMD clinics. Even the pharmacy enterprise has confronted competitors from nimble, on-line pharmacy retailers corresponding to Amazon Pharmacy and Mark Cuban's Price Plus Medication and has fallen sufferer to drug value negotiations.

And buyers have been listening to its missteps. Over the previous 5 years, the retail big's share value has, if we will even use that time period, floundered; the inventory is presently buying and selling at lower than $10, down from a excessive of just about $40 in late 2019.

So when the Wall Road Journal reported final week that Deerfield, Sick.-based Walgreens is exploring a sale, shares of the struggling retailer rose about 17% that day.

If a deal have been to occur, there may very well be a possible buyout of about $9.2 billion to $10 billion, Erin Wright, an fairness analyst at Morgan Stanley, wrote in a analysis observe following the WSJ report. Based on the Monetary Occasions, it is a poor selection contemplating world funding agency KKR made a $70 billion supply to purchase Walgreens in 2019. A report from Pitchbook discovered that the deal reportedly stalled as a result of KKR and its potential backers couldn’t agree on Walgreens' valuation.

Given its diminished standing, is promoting to a non-public fairness purchaser a very good transfer for Walgreens?

The reply appears to be “sure” for some consultants.

“At this level, a contemporary perspective is required to reconceptualize the best way to deploy the corporate's property extra fruitfully,” stated Michael Abrams, managing accomplice of Numerof & Associates, a consulting agency.

Walgreens and Sycamore Companions declined to remark.

Why Walgreens needs to promote itself

Rumors that Walgreens is contemplating a sale come after practically a decade of efforts to revive development, based on Abrams. Throughout that point, the market worth fell from greater than $100 billion to lower than $8 billion, he stated.

He added that the corporate has tried quite a few methods to show issues round, together with increasing into Europe with the acquisition of Alliance Boots and shopping for a stake in major care supplier VillageMD for about $5.2 billion.

“The very fact is that the pharmacy business is mature, with flat margins in its core operate of shelling out prescribed drugs,” Abrams stated. “Add to that rising strain from pharmacy profit managers who negotiate drug costs on behalf of insurers and employers, and Walgreens' extraordinary community of greater than 12,000 shops is much less an asset than a legal responsibility.”

He added that retail product gross sales are going through rising competitors from Amazon and different e-commerce websites.

The hope is that the sale to a non-public fairness agency might help Walgreens make operational enhancements and develop, stated Keith Campbell, the chief of West Monroe's mergers and acquisitions apply. West Monroe is a consulting agency.

“By closing underperforming areas and utilizing sale-and-leaseback transactions, Walgreens can cut back debt and streamline operations,” Campbell stated. “As soon as retail operations have stabilized and money stream is optimistic, the main target may shift to high-growth segments corresponding to dwelling care and uncommon/orphan drug compounding.”

However why Sycamore Companions? In spite of everything, the corporate doesn’t have a lot expertise in healthcare. It has traditionally performed smaller offers than Walgreens and would seemingly need to promote elements of its enterprise or herald companions to finish the deal, Abrams identified.

The principle attraction may very well be that the New York-based firm focuses on retail and client investments. Abrams acknowledged that his portfolio contains workplace provide retailer Staples and outfitters Scorching Matter, Ann Taylor and Chico's.

The truth that Sycamore Companions is extra retail-oriented and consumer-oriented is of curiosity to Hal Andrews, president and CEO of Trilliant Well being. He famous that the wonder sector is as outstanding because the pharmacy sector in Boots shops in London, if no more so.

“Boots, simply from an expertise perspective, may be very a lot a client firm round well being, wellness and sweetness. … However well being care is one thing utterly totally different,” he stated. “The truth that Sycamore is means that they see a chance to essentially deal with the retail aspect, the patron aspect, the well being and sweetness aspect of the enterprise, and never a lot on the healthcare aspect, whether or not that's VillageMD or Shields or one thing like that. in any other case, it’s really hands-on medication, versus retail well being.”

Is that this the appropriate transfer?

At this level, promoting to a non-public fairness purchaser like Sycamore Companions may very well be the appropriate choice for Walgreens, Abrams stated.

“Walgreens missed the chance to diversify into the PBM or insurance coverage sectors years in the past, and so has been left on the mercy of others like CVS who did,” he acknowledged. “Their try to enter major care made sense, however the firm underestimated the price and energy concerned in altering the general public's expectations to view the native drugstore as a healthcare supplier.”

One other guide echoed Abrams' feedback, noting that the faltering retail big should make a strategic change to keep away from “additional decline.”

“I feel a non-public fairness proprietor at this level may probably drive the mandatory modifications, corresponding to an elevated deal with e-commerce, rethinking the retail footprint and pursuing mergers and acquisitions to increase into adjoining healthcare providers,” says Howard Gutman, non-public fairness technique and protection chief for MorganFranklin Consulting. “Nonetheless, efficiently executing this transformation would require Walgreens to develop new capabilities round digital operations, M&A integration and managing a extra diversified enterprise mannequin. That is another excuse why I feel the transfer to seek out the appropriate non-public fairness accomplice is smart.”

Trilliant Well being's Andrews acknowledged that he can’t say for sure whether or not that is the appropriate transfer for Walgreens. As an govt, nonetheless, he did observe that when an organization must restructure a enterprise, it's a lot simpler to take action should you're privately held and don't report back to Wall Road each 90 days.

“It permits the administration workforce to focus solely on the targets and never fear about what Wall Road goes to say each 90 days or whether or not the inventory will go up or down,” he stated. “It offers readability, and readability offers extra deal with executing the plan, somewhat than worrying about what individuals suppose.”

Whereas a non-public fairness deal could appear to be a smart move for Walgreens to some, Morgan Stanley's Wright doesn't appear to suppose the deal will undergo.

“Whereas we acknowledge the context surrounding a possible sale in a difficult pharmacy surroundings, an acquisition is harder to think about given the corporate's already important debt burden and meager money stream, making the worth creation path harder to decipher,” Wright stated within the analyst observe.

Andrews added that Sycamore Companions might not be the one get together in Walgreens and that there may nicely be extra potential patrons on the best way with competing gives.

“That is actually simply the 1st step, and it is going to be attention-grabbing to see if one other non-public fairness agency steps in,” he stated.

Picture: Alexsl, Getty Photographs